Coagulation and adulteration--building on science and policy lessons from 1905.
作者信息
Avorn Jerry
机构信息
Harvard Medical School, Harvard Interfaculty Initiative on Medications and Society, and Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, Boston, USA.
出版信息
N Engl J Med. 2008 Jun 5;358(23):2429-31. doi: 10.1056/NEJMp0803685.
PMID:18525040
Abstract
摘要
相似文献
1
Coagulation and adulteration--building on science and policy lessons from 1905.凝血与掺假——基于1905年的科学与政策教训
N Engl J Med. 2008 Jun 5;358(23):2429-31. doi: 10.1056/NEJMp0803685.
2
Sure cure: public policy on drug efficacy before 1962.确切的治愈方法：1962年以前关于药物疗效的公共政策。
Publ Am Inst Hist Pharm. 1997;16:223-61.
3
Using market-exclusivity incentives to promote pharmaceutical innovation.利用市场独占激励措施促进药物创新。
N Engl J Med. 2010 Nov 4;363(19):1855-62. doi: 10.1056/NEJMhle1002961.
4
Shifting terrain in the regulation of off-label promotion of pharmaceuticals.药品未标示用途推广监管方面不断变化的形势。
N Engl J Med. 2009 Apr 9;360(15):1557-66. doi: 10.1056/NEJMhle0807695.
5
The ongoing regulation of generic drugs.仿制药的持续监管。
N Engl J Med. 2007 Nov 15;357(20):1993-6. doi: 10.1056/NEJMp078193.
6
7
Regulators scramble to tighten loopholes after heparin debacle.肝素事件后，监管机构匆忙收紧漏洞。
Nat Biotechnol. 2008 May;26(5):477-8. doi: 10.1038/nbt0508-477.
8
American roulette--contaminated dietary supplements.美式轮盘赌——受污染的膳食补充剂。
N Engl J Med. 2009 Oct 15;361(16):1523-5. doi: 10.1056/NEJMp0904768. Epub 2009 Oct 7.
9
Food and Drug Administration: 100 years of protection.美国食品药品监督管理局：100年的保护历程。
Home Healthc Nurse. 2007 Mar;25(3):148-50. doi: 10.1097/01.NHH.0000263429.92814.55.
10
Pharmaceutical patent life-cycle management after KSR v. Teleflex.KSR诉泰利福公司案后的药品专利生命周期管理
Food Drug Law J. 2008;63(1):275-320.
Zotero 插件